Literature DB >> 14769372

Evidence that lipopolysaccharide-induced cell death is mediated by accumulation of reactive oxygen species and activation of p38 in rat cortex and hippocampus.

Yvonne Nolan1, Emily Vereker, Aileen M Lynch, Marina A Lynch.   

Abstract

Lipopolysaccharide (LPS) administration stimulates immune activation, inflammation and deterioration in cell function. Neuronal tissue in cortex and hippocampus are particularly susceptible. In this study, we report that LPS induces cell death as measured by caspase-3 activation and DNA fragmentation and that this is coupled with stimulation of the mitogen-activated protein kinase, p38. We provide evidence of co-localization of activated p38 and caspase-3 in cells prepared from cortical and hippocampal tissue after LPS treatment. Furthermore, administration of the p38 inhibitor, SB203580, abolished the LPS-induced increase in caspase-3 activation. We observed that LPS treatment provoked accumulation of reactive oxygen species (ROS) while in vitro incubation of cortical and hippocampal tissue with H(2)O(2) increased p38 activity. In addition, H(2)O(2)-induced activation of caspase-3 was abrogated by SB203580. We propose, based on the data presented, that the action of LPS to induce cell death in cortex and hippocampus may be mediated by ROS accumulation and activation of p38.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14769372     DOI: 10.1016/S0014-4886(03)00301-7

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  24 in total

1.  Salmonella lipopolysaccharide (LPS) mediated neurodegeneration in hippocampal slice cultures.

Authors:  Sara Johansson; Svante Bohman; Ann-Cathrin Radesäter; Caroline Oberg; Johan Luthman
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

Review 2.  Toll-like receptors in defense and damage of the central nervous system.

Authors:  Rajagopal N Aravalli; Phillip K Peterson; James R Lokensgard
Journal:  J Neuroimmune Pharmacol       Date:  2007-04-03       Impact factor: 4.147

3.  Hippocampus: a future target for sepsis treatment!

Authors:  Djillali Annane
Journal:  Intensive Care Med       Date:  2009-01-21       Impact factor: 17.440

Review 4.  Mitogen-Activated Protein Kinase Phosphatase (MKP)-1 in Nervous System Development and Disease.

Authors:  Louise M Collins; Eric J Downer; André Toulouse; Yvonne M Nolan
Journal:  Mol Neurobiol       Date:  2014-06-24       Impact factor: 5.590

5.  Upregulation of CBLL1 in rat brain cortex after lipopolysaccharide treated.

Authors:  Maohong Cao; Heyi Zheng; Xiang Tan; Wei Xu; Ying Rui; Lei Li; Xiaofei Liu; Guangfei Xu; Gang Cui; Jian Xu; Jianhua Cao; Kaifu Ke; Qiyun Wu
Journal:  J Mol Histol       Date:  2012-11-17       Impact factor: 2.611

6.  Effect of taurine on brain 8-hydroxydeoxyguanosine and 3-nitrotyrosine levels in endotoxemia.

Authors:  Gonca Ozan; Nurten Turkozkan; Filiz Sezen Bircan; Barbaros Balabanli
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

Review 7.  Models of neurodevelopmental abnormalities in schizophrenia.

Authors:  Susan B Powell
Journal:  Curr Top Behav Neurosci       Date:  2010

8.  Deciphering the dual effect of lipopolysaccharides from plant pathogenic Pectobacterium.

Authors:  Kettani-Halabi Mohamed; Tran Daniel; Dauphin Aurélien; Hayat El-Maarouf-Bouteau; Errakhi Rafik; Delphine Arbelet-Bonnin; Bernadette Biligui; Val Florence; Ennaji Moulay Mustapha; Bouteau François
Journal:  Plant Signal Behav       Date:  2015

9.  Decreased glutathione levels potentiate the apoptotic efficacy of selenium: possible involvement of p38 and JNK MAPKs--in vitro studies.

Authors:  Pavitra Ranawat; M P Bansal
Journal:  Mol Cell Biochem       Date:  2007-11-08       Impact factor: 3.396

10.  Mitogen-activated protein kinase phosphatase (MKP)-1 as a neuroprotective agent: promotion of the morphological development of midbrain dopaminergic neurons.

Authors:  Louise M Collins; Gerard W O'Keeffe; Caitriona M Long-Smith; Sean L Wyatt; Aideen M Sullivan; André Toulouse; Yvonne M Nolan
Journal:  Neuromolecular Med       Date:  2013-04-13       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.